Zentalis Pharmaceuticals Balance Sheet (2019-2026) | ZNTL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Receivables - Accured (Quarter)	0.33M	0.29M	0.26M	0.27M	0.47M	0.42M	0.51M	0.39M	0.88M	1.93M	3.34M	3.15M	3.28M	3.31M	2.94M	2.74M	2.45M	2.15M	1.93M	2.10M
Assets
Current Assets
Cash & Equivalents (Quarter)	49.17M	40.81M	59.71M	30.57M	55.14M	42.55M	43.07M	36.28M	266.56M	110.75M	28.04M	37.62M	36.98M	41.32M	33.90M	41.93M	37.60M	39.07M	35.99M	31.93M
Receivables - Net (Quarter)	0.01M	0.11M	0.00M												5.00M
Receivables - Other (Quarter)		2.94M	2.37M	2.35M	2.98M	3.23M	5.87M	7.91M
Receivables (Quarter)	0.01M	3.05M	2.38M												5.00M
Prepaid Assets (Quarter)	8.30M	16.46M	10.64M	11.67M	24.34M	22.40M	14.56M	17.71M	18.86M	11.63M	20.62M	14.82M	13.23M	9.02M	14.40M	13.77M	11.39M	7.61M	11.41M	10.43M
Current Assets (Quarter)	259.45M	377.56M	350.77M	301.28M	467.63M	433.89M	451.93M	410.23M	563.93M	528.26M	496.72M	503.81M	439.62M	400.27M	386.07M	342.88M	311.60M	288.30M	253.19M	218.10M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	2.25M	4.70M	8.15M	8.48M	8.22M	8.03M	7.71M	6.88M	6.65M	6.39M	5.82M	5.68M	5.34M	5.02M	4.70M	3.25M	3.09M	2.93M	2.77M	2.65M
Long-Term Investments (Quarter)		39.33M	37.49M	35.74M	30.41M	28.04M	21.21M	18.90M			454.88M	451.37M	389.41M	349.93M
Goodwill (Quarter)	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M
Intangibles (Quarter)	8.80M
Goodwill & Intangibles (Quarter)	12.54M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M	3.74M
Other Non-Current Assets (Quarter)	3.26M	3.26M	2.63M	2.87M	2.63M	2.63M	2.63M	2.63M	2.63M	2.63M	2.68M	2.68M	2.68M	2.63M	4.42M	2.63M	2.63M	2.63M	2.63M	4.09M
Non-Current Assets (Quarter)	24.51M	57.52M	103.74M	104.39M	100.23M	95.30M	87.38M	79.12M	57.52M	57.45M	54.97M	53.67M	52.06M	50.39M	44.27M	41.14M	40.11M	38.95M	35.78M	34.97M
Assets (Quarter)	283.96M	435.08M	454.51M	405.68M	567.86M	529.19M	539.31M	489.34M	621.44M	585.72M	551.69M	557.48M	491.68M	450.66M	430.34M	384.02M	351.71M	327.25M	288.97M	253.07M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	8.27M	8.05M	11.59M	13.16M	12.04M	9.82M	11.25M	12.82M	12.30M	14.26M	14.93M	10.50M	20.44M	8.20M	7.44M	7.77M	3.72M	7.03M	7.21M	7.38M
Payables (Quarter)	8.27M	8.05M	11.59M	13.16M	12.04M	9.82M	11.25M	12.82M	12.30M	14.26M	14.93M	10.50M	20.44M	8.20M	7.44M	7.77M	3.72M	7.03M	7.21M	7.38M
Accumulated Expenses (Quarter)	25.30M	31.37M	32.35M	30.32M	36.59M	44.24M	45.40M	43.54M	39.45M	44.65M	54.44M	44.30M	46.25M	46.67M	45.29M	41.66M	35.30M	30.14M	29.35M	27.86M
Total Current Liabilities (Quarter)	33.58M	39.41M	43.94M	43.48M	48.64M	54.06M	56.65M	56.36M	51.76M	58.92M	69.37M	54.80M	66.69M	54.88M	52.73M	49.43M	39.02M	37.17M	36.56M	35.24M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)	23.76M	0.56M	0.53M	0.37M	0.33M	0.23M	0.22M	0.18M	0.14M	0.13M	0.11M
Operating Leases (Quarter)			44.46M				45.17M	44.77M	46.36M	45.69M	43.15M	45.35M	41.32M	40.46M	39.58M	38.65M	37.69M	36.71M	35.70M	34.65M
Non-Current Deferred Tax Liability (Quarter)	2.48M	1.67M	1.62M	1.55M	1.32M	1.23M	0.85M	0.76M			10.34M
Other Non-Current Liabilities (Quarter)	0.30M		1.00M	44.98M			2.62M	1.79M	0.50M	1.63M	1.78M	1.29M	1.09M	1.00M	0.85M	0.56M	0.50M	0.50M	0.50M	0.50M
Total Non-Current Liabilities (Quarter)	36.06M	41.09M	89.03M	45.03M	95.03M	100.45M	102.67M	101.89M	97.66M	102.18M	112.52M	97.41M	108.01M	95.33M	92.30M	88.08M	76.71M	73.88M	72.26M	69.89M
Total Liabilities (Quarter)	36.35M	41.09M	90.03M	90.01M	95.03M	100.45M	105.29M	103.68M	98.16M	103.82M	114.30M	98.71M	109.10M	96.33M	93.15M	88.64M	77.21M	74.38M	72.76M	70.39M
Shareholder's Equity
Common Equity (Quarter)	247.61M	394.00M	364.48M	315.67M	472.82M	428.74M	434.02M	385.67M	523.28M	481.90M	437.28M	458.77M	382.58M	354.33M	337.19M	295.38M	274.50M	252.87M	216.20M	182.68M
Shareholder's Equity (Quarter)	247.61M	394.00M	364.48M	315.67M	472.82M	428.74M	434.02M	385.67M	523.28M	481.90M	437.28M	458.77M	382.58M	354.33M	337.19M	295.38M	274.50M	252.87M	216.20M	182.68M
Liabilities and Shareholders Equity (Quarter)	283.96M	435.08M	454.51M	405.68M	567.86M	529.19M	539.31M	489.34M	621.44M	585.72M	551.69M	557.48M	491.68M	450.66M	430.34M	384.02M	351.71M	327.25M	288.97M	253.07M
Retained Earnings (Quarter)	-305.31M	0.03M	-359.56M	-418.64M	-1.78M	-2.27M	-596.37M	-659.58M	-0.34M	-827.64M	2.19M	-878.49M	-966.76M	-1006.92M	0.56M	-1102.67M	-1129.55M	0.19M	0.20M	-1226.81M
Treasury Shares (Quarter)			0.27M				0.13M				949.00				7.50M				5.36M
Shares Outstanding (Quarter)	41.31M	45.20M	45.49M	45.58M	56.97M	57.00M	59.28M	59.44M	70.60M	70.64M	70.77M	71.01M	71.11M	71.15M	71.28M	71.95M	72.14M	72.25M	69.09M	71.16M

Research Tools

Developers

Zentalis Pharmaceuticals Balance Sheet (2019-2026) | ZNTL

Research Tools

Developers

Zentalis Pharmaceuticals Balance Sheet (2019-2026) | ZNTL

Create an account

Sign In

Reset Password